Stockholm - Delayed Quote SEK

ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)

22.75
-0.10
(-0.44%)
At close: June 5 at 4:47:11 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,013
3,013
7,050
5,086
12,234
Cost of Revenue
5,681
5,681
3,647
5,081
7,513
Gross Profit
-2,668
-2,668
3,403
5
4,721
Operating Expense
65,027
65,027
109,368
127,611
53,117
Operating Income
-67,695
-67,695
-105,965
-127,606
-48,396
Net Non Operating Interest Income Expense
987
987
1,410
1,025
209
Pretax Income
-44,563
-44,563
-99,967
-126,581
-47,516
Tax Provision
-8,148
-8,148
-8,566
-7,976
-3,591
Net Income Common Stockholders
-36,415
-36,415
-91,401
-118,605
-43,925
Diluted NI Available to Com Stockholders
-36,415
-36,415
-91,401
-118,605
-43,925
Basic EPS
-21.54
-21.54
-79.25
-100.26
-42.46
Diluted EPS
-21.54
-21.54
-79.25
-100.26
-42.46
Basic Average Shares
1,690.94
1,690.94
1,153.38
1,183
1,034.57
Diluted Average Shares
2,596.48
2,596.48
1,254.63
1,183
1,034.57
Total Operating Income as Reported
-67,695
-67,695
-105,965
-127,606
-48,396
Total Expenses
70,708
70,708
113,015
132,692
60,630
Net Income from Continuing & Discontinued Operation
-36,415
-36,415
-91,401
-118,605
-43,925
Normalized Income
-36,415
-36,415
-91,401
-118,605
-43,925
Interest Income
1,714
1,714
1,911
1,896
209
Interest Expense
727
727
501
871
0
Net Interest Income
987
987
1,410
1,025
209
EBIT
-43,836
-43,836
-99,466
-125,710
-47,516
EBITDA
-42,195
-42,195
-97,865
-124,494
-45,707
Reconciled Cost of Revenue
5,681
5,681
3,647
5,081
7,513
Reconciled Depreciation
1,641
1,641
1,601
1,216
1,809
Net Income from Continuing Operation Net Minority Interest
-36,415
-36,415
-91,401
-118,605
-43,925
Normalized EBITDA
-42,195
-42,195
-97,865
-124,494
-45,707
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/29/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HNSA.ST Hansa Biopharma AB (publ)
24.20
-0.74%
 
SANION.ST Saniona AB (publ)
9.30
-3.23%
 
FLUO.ST FluoGuide A/S
41.90
+1.95%
 
ONCO.ST Oncopeptides AB (publ)
1.5240
+0.26%
 
BAVA.CO Bavarian Nordic A/S
180.40
+0.50%
 
XSPRAY.ST Xspray Pharma AB (publ)
31.30
0.00%
 
2CUREX.ST 2cureX AB (publ)
4.9100
+10.84%
 
8GN.F Cessatech A/S
1.8900
0.00%
 
ANNX.ST Annexin Pharmaceuticals AB (publ)
34.70
+8.44%
 
BIOSGN.ST Biosergen AB
0.6360
0.00%